Tandem Diabetes Care Inc (FRA:TD5A)
€ 46.5 -0.61 (-1.29%) Market Cap: 3.09 Bil Enterprise Value: 3.10 Bil PE Ratio: 0 PB Ratio: 13.74 GF Score: 77/100

Tandem Diabetes Care Inc at Cowen Healthcare Conference (Virtual) Transcript

Mar 02, 2021 / 04:50PM GMT
Release Date Price: €79.08 (-1.03%)
Chris Lin
Cowen and Company, LLC, Research Division - VP of Health Care - Life Science and Diagnostic Tools

All right. Good morning, everyone. I'm Chris Lin, one of the Cowen's healthcare analysts. It is my pleasure to welcome Tandem Diabetes Care to our conference.

From the company, we have John Sheridan, who is President and CEO; and Leigh Vosseller, who is CFO. I believe John has a few minutes of prepared remarks before we jump into the Q&A session.

So with that, why don't I just hand it over to John.

John F. Sheridan
Tandem Diabetes Care, Inc. - President, CEO & Director

Thanks, Chris. It's great to be here today. I guess, I'd just like to start off by kind of just recapping some of the comments we made in our call this past week. We had a fantastic 2020. We eclipsed -- almost eclipsed $0.5 billion in sales. We had over 200,000 people using our pump worldwide, which is -- it's almost halfway there to what we said we would accomplish in the next 3 to 5 years. So we're very excited about that.

We obviously got the UNC

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot